{"id":543,"date":"2018-09-19T16:49:07","date_gmt":"2018-09-19T14:49:07","guid":{"rendered":"https:\/\/biologika-register.de?page_id=543"},"modified":"2018-09-19T16:54:30","modified_gmt":"2018-09-19T14:54:30","slug":"goal-safety-in-therapy","status":"publish","type":"page","link":"https:\/\/biologika-register.de\/en\/rabbit\/information-on-the-study-for-doctors\/goal-safety-in-therapy\/","title":{"rendered":"Goal: Safety in therapy"},"content":{"rendered":"<p>The most important concern of the Registry is to assess the safety of treatment for rheumatoid arthritis.<\/p>\n<p><b>Adverse events (UE) and serious adverse events (SUE) <\/b>are all medically relevant occurrences during the observation period, irrespective of any possible causal relationship with a therapy.<\/p>\n<p>Pregnancies of the patient&#8217;s partner are also medically relevant. We therefore ask you to document a pregnancy, even if it is planned and desired, in the same way as an &#8220;adverse event&#8221;.<\/p>\n<h2>Adverse events<\/h2>\n<ul>\n<li>all newly occurring subjective and objective diseases or symptoms<\/li>\n<li>  all adverse drug reactions, in particular allergic reactions and infusion incidents<\/li>\n<li> UE lasting since last measurement time<\/li>\n<li>worsening of concomitant diseases<\/li>\n<li>Pregnancies, births, abortions, miscarriages<\/li>\n<\/ul>\n<h2>Serious adverse events<\/h2>\n<ul>\n<li>UE with death result<\/li>\n<li>life-threatening UE<\/li>\n<li>UE with hospital stay (also planned operations, but no inpatient rehabilitation)<\/li>\n<li>Malformations, birth defects<\/li>\n<li>UE leading to persistent or significant functional impairment or disability<\/li>\n<li>other UE associated with an acute or significant risk (e.g. allergic bronchospasm, seizure)<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>The most important concern of the Registry is to assess the safety of treatment for rheumatoid arthritis. Adverse events (UE) &#8230; <a title=\"Goal: Safety in therapy\" class=\"read-more\" href=\"https:\/\/biologika-register.de\/en\/rabbit\/information-on-the-study-for-doctors\/goal-safety-in-therapy\/\" aria-label=\"Read more about Goal: Safety in therapy\">mehr<\/a><\/p>\n","protected":false},"author":7,"featured_media":0,"parent":579,"menu_order":3,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_crdt_document":"","generate_page_header":"","footnotes":""},"class_list":{"0":"post-543","1":"page","2":"type-page","3":"status-publish","5":"infinite-scroll-item"},"_links":{"self":[{"href":"https:\/\/biologika-register.de\/en\/wp-json\/wp\/v2\/pages\/543","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biologika-register.de\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/biologika-register.de\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/biologika-register.de\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/biologika-register.de\/en\/wp-json\/wp\/v2\/comments?post=543"}],"version-history":[{"count":5,"href":"https:\/\/biologika-register.de\/en\/wp-json\/wp\/v2\/pages\/543\/revisions"}],"predecessor-version":[{"id":1664,"href":"https:\/\/biologika-register.de\/en\/wp-json\/wp\/v2\/pages\/543\/revisions\/1664"}],"up":[{"embeddable":true,"href":"https:\/\/biologika-register.de\/en\/wp-json\/wp\/v2\/pages\/579"}],"wp:attachment":[{"href":"https:\/\/biologika-register.de\/en\/wp-json\/wp\/v2\/media?parent=543"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}